Sunshine Heart Inc news

   Watch this stock
Showing stories 1 - 10 of about 70   

Articles published

SSH 0.863 -0.077 (-8.16%)
price chart
Company Update (NASDAQ:SSH): Sunshine Heart Inc Announces Clinical Update and ...
Sunshine Heart Inc (NASDAQ:SSH) announced an update to its clinical strategy that could benefit an underserved population of patients with Class III heart failure and other related conditions.
Sunshine Heart Announces Clinical Update and Product Development Strategy  Yahoo Finance
Tracking Unusual Volume on Shares of: Sunshine Heart Inc. (NASDAQ:SSH)  Engelwood Daily
Sunshine Heart Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
EDEN PRAIRIE, Minn., June 24, 2016 (GLOBE NEWSWIRE) -- Sunshine Heart, Inc. (NASDAQ:SSH), today announced that on June 22, 2016, the Compensation Committee of its Board of Directors, which is composed entirely of independent directors, ...
[550]How Analysts Rated Sunshine Heart Inc (NASDAQ:SSH) Last Week?
Out of 2 analysts covering Sunshine Heart (NASDAQ:SSH), 1 rate it a “Buy”, 0 “Sell”, while 1 “Hold”. This means 50% are positive.
Sunshine Heart Announces $3.5 Million Offering
EDEN PRAIRIE, Minn., July 21, 2016 (GLOBE NEWSWIRE) -- Sunshine Heart, Inc. (Nasdaq:SSH) (“Sunshine Heart” or the “Company”), today announced that it has entered into a definitive agreement with a single investor for an offering of shares of ...
Notable Buzzers: Aetna Inc. (NYSE:AET) , Sunshine Heart Inc (NASDAQ:SSH)  Street Updates
Analyst Ratings Buzz: Sunshine Heart Inc. (NASDAQ:SSH)  News Oracle
Sunshine Heart Names a New CEO
EDEN PRAIRIE, Minn., March 02, 2016 (GLOBE NEWSWIRE) -- Sunshine Heart, Inc. (Nasdaq:SSH) announced today the appointment of John Erb as its fulltime Chief Executive Officer (CEO) and President, effective immediately.
Sunshine Heart's (SSH) CEO John Erb on Q4 2015 Results - Earnings Call ...  Seeking Alpha
Can Sunshine Heart Survive To See The Dawn?
The market has turned very hostile toward high-risk small-cap med-tech companies, and Sunshine Heart (NASDAQ:SSH) has long struggled to deliver the sort of progress that would make it easy to argue that the market is being unfair.
A Cardiologist's Perspective On Sunshine Heart
Sunshine Heart (NASDAQ:SSH) has had a tough past in that its study was initially halted by the FDA for deaths that were found not to be related to the study device, which led to a delay/cessation in recruitment of new study center, but is now back on ...
Sunshine Heart - A Speculative Biotech Play For Substantial Short-Term Gains
Sunshine Heart develops the C-Pulse device for HF (Heart-Failure) patients. C-Pulse showed outstanding clinical results in the US feasibility study, and EU study, including improvement in HF condition, and recovery.
Sunshine Heart Inc: The Lance Armstrong Effect Setting C-Pulse Apart
The C-Pulse system applies this concept in an innovative way. Through the application of a balloon wrapped around the outside of the aorta, the C-Pulse System inflates and deflates the balloon in rhythm with the natural heartbeat, applying a “secondary ...
Clouds Still Mar Sunshine Heart's Outlook
Development-stage med-tech Sunshine Heart (NASDAQ:SSH) has had a good run up from its mid-December lows, and the company continues to move forward with the clinical development of a device-based approach for congestive heart failure that could ...